Is EWTX a good stock to buy? We came across a bullish thesis on Edgewise Therapeutics, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on EWTX. Edgewise Therapeutics, Inc.’s share was trading at $38.83 as of June 23rd.
Pressmaster/Shutterstock.com
Edgewise Therapeutics is positioned as a high-conviction clinical-stage biotech transitioning into a substantially de-risked financial structure following the divestiture of its muscular dystrophy...
